Philips Medical Systems Nederland B.V. recalled 268 Allura Xper FD20 Biplane systems on September 3, 2025. The recall affects units distributed globally due to potential failures in internal components. If malfunction occurs, motorized movements will be disabled, posing risks to operational efficiency.
Systems may not perform as intended due to the deterioration of certain internal components (the CMOS battery, hard disk drive, and/or power supply unit). If this deterioration occurs, motorized movements of the system will become unavailable. Manual movements of the stand (longitudinal, transversal and rotational for ceiling mounted systems and rotational for floor mounted systems) and table longitudinal movements remain available. Imaging (X-ray) functionality remains available.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. or your healthcare provider for instructions. Notification method: Letter
The recalled product includes Allura Xper FD20 Biplane systems with product codes 722013 and 722008. The recall involves 268 units, with 102 sold in the U.S. and 166 distributed internationally.
The imaging systems may fail to perform as intended due to the deterioration of internal components such as the CMOS battery, hard disk drive, and power supply unit. If this happens, motorized movements of the system will be unavailable, which could impact patient care.
No specific incidents or injuries have been reported in relation to this recall. The risk remains high due to the potential for operational failure.
Stop using the recalled imaging systems immediately. Contact Philips Medical Systems for further instructions and follow the provided recall guidelines.
For more information, call Philips Medical Systems at 1-800-XXX-XXXX or visit their website at www.philips.com.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.